MAP1LC3A and breast cancer: In 4T1.2 mammary tumor cells, administration of A77636 elevated the level of cleaved caspase 3 as a marker of apoptosis12, as well as the level of LC3-phosphatidylethanolamine conjugate (LC3II) as an autophagosome marker13.